Abstract:The paper gives the experience with Buserelin-long FS used to treat 17 patients aged 47 to 60 years with locally advanced and generalized prostate cancer. Analysis of the results of treatment following 2, 4, and 6 months has shown that the mean levels of testosterone and prostate-specific antigen reduced drastically after just 2 months. There is a simultaneous improvement in the quality of life.
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.